{
    "code": "02022094",
    "time": "2015-06-25 17:25:12",
    "許可證字號": "衛署藥輸字第022094號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/03\/06",
    "發證日期": "87\/03\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202209401",
    "中文品名": "理思必妥內服液劑１毫克\/毫升",
    "英文品名": "RISPERDAL ORAL SOLUTION 1MG\/ML",
    "適應症": "精神分裂症之相關症狀，雙極性疾患之躁症發作。治療失智症病人具嚴重攻擊性，或精神分裂症類似症狀。",
    "劑型": "170內服液劑",
    "包裝": "瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RISPERIDONE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段319號4、5樓",
    "主製造廠": {
        "製造廠名稱": "F050009000  JANSSEN PHARMACEUTICA N.V.",
        "製造廠廠址": "TURNHOUTSEWEG 30 B-2340 BEERSE",
        "製造廠公司地址": "",
        "製造廠國別": "BELGIUM",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100600",
            "成分名稱": "RISPERIDONE",
            "含量描述": "1.0",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020220940001-104-01-13.pdf 020220940001-102-11-12.pdf 020220940020.jpg 020220940019.jpg 020220940018.jpg 020220940017.jpg 020220940016.jpg 020220940015.jpg 020220940014.jpg 020220940013.jpg 020220940012.jpg 020220940011.jpg 020220940010.jpg 020220940009.jpg 020220940008.jpg 020220940007.jpg 020220940006.jpg 020220940005.jpg 020220940004.jpg 020220940003.jpg 020220940002.jpg 020220940001___20121130.pdf 020220940001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02022094&Seq=023&Type=9"
        }
    ]
}